GlassScriptPhysician profile
Kyle Scott Garcia
NPI 1558824763
$2,459.26
in general payments reported to CMS, 2019-2025
21 companies · $460 in 2025
The $460 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.96 · 2022: $326 · 2023: $452 · 2024: $1,201 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,149 · Travel and Lodging: $789 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,149.13 |
| Travel and Lodging | $788.78 |
| Education | $174.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $857.32 | 2023-2024 | |
| Boston Scientific Corporation | $425.13 | 2022-2024 | Ams 700, Lithovue, Moses 550 Dfl |
| Coloplast Corp | $190.12 | 2022-2023 | Porges Coloplast |
| Endo USA, INC. | $170.56 | 2024-2025 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $121.83 | 2023 | Jelmyto |
| Smith+Nephew, INC. | $108.68 | 2024 | Stravix |
| Seagen INC. | $99.99 | 2025 | |
| 180 Medical, INC. | $96.02 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $74.99 | 2023 | Lynparza |
| Sumitomo Pharma America, INC. | $49.42 | 2025 | Gemtesa |
| Karl Storz Endoscopy-America | $40.60 | 2022-2023 | N.A. |
| Conmed Corporation | $38.46 | 2023 | Airseal |
| Valencia Technologies Corporation | $25.51 | 2025 | Ecoin Device Kit |
| Pfizer INC. | $23.91 | 2025 | |
| Glaxosmithkline, LLC. | $22.26 | 2025 | Bexsero, Penmenvy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $21.48 | 2025 | Interstim |
| Ferring Pharmaceuticals INC. | $20.35 | 2025 | Adstiladrin |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.96 | 2021 | |
| Procept Biorobotics Corporation | $19.57 | 2025 | |
| Olympus America INC. | $18.62 | 2025 | Itind System |
| Janssen Biotech, INC. | $14.48 | 2025 | Erleada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.